Phase I Study of KN044 in Locally Advanced/Metastatic Solid Tumors
Changchun Intellicrown Pharmaceutical Co. LTD
Changchun Intellicrown Pharmaceutical Co. LTD
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Ottawa Hospital Research Institute
Universitair Ziekenhuis Brussel
Nanfang Hospital, Southern Medical University
Sun Yat-sen University
Maria Sklodowska-Curie National Research Institute of Oncology
Barwon Health
National Taiwan University Hospital
Guangdong Provincial People's Hospital
IRCCS Azienda Ospedaliero-Universitaria di Bologna